BioCentury
ARTICLE | Financial News

Recro financial update

February 9, 2015 8:00 AM UTC

Recro Pharma Inc. (NASDAQ:REPH), Malvern, Pa. Business: Neurology Date announced: 2015-02-02 Note: Recro entered into a two-year stock purchase agreement with Aspire Capital for up to $10 million. ...